Evidence map›Paper›PMID 35344227›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2022

A myosin chaperone, UNC-45A, is a novel regulator of intestinal epithelial barrier integrity and repair.

Susana Lechuga, Alexander X Cartagena-Rivera, Afshin Khan, Bert I Crawford, Vani Narayanan, Daniel E Conway, Jaakko Lehtimäki, Pekka Lappalainen, Florian Rieder, Michelle S Longworth and 1 more

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. A myosin chaperone, UNC-45A, is a novel regulator of intestinal epithelial barrier integrity and repair.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Susana LechugaDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Alexander X Cartagena-RiveraSection on Mechanobiology, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0001-6227-2499
Afshin KhanDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Bert I CrawfordDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Vani NarayananDepartment of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.
Daniel E ConwayDepartment of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.
Jaakko LehtimäkiInstitute of Biotechnology and Helsinki Institute of Life Sciences, University of Helsinki, Helsinki, Finland.
Pekka LappalainenInstitute of Biotechnology and Helsinki Institute of Life Sciences, University of Helsinki, Helsinki, Finland.
Florian RiederDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Michelle S LongworthDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Andrei I IvanovDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.ORCID 0000-0003-4823-209X
Cleveland Clinic · USUniversity of Helsinki · FIVirginia Commonwealth University · USNational Institutes of Health · US

Funding

MechanobiologyZIAEB000094 · NIBIB · NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING · PI CARTAGENA-RIVERA, ALEXANDER · 2020 to 2025
$6.0M
Cell junction and nuclear forces as mediators of epithelial cell homeostasisR35GM119617 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI Daniel E Conway · 2016 to 2026
$4.5M
Creeping fat and Crohn's disease associated stricturesR01DK123233 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI RIEDER, FLORIAN · 2020 to 2024
$1.9M
Actomyosin cytoskeleton and the regulation of intestinal eipithelial barrierR01DK108278 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI IVANOV, ANDREI IVANOVICH · 2016 to 2019
$1.4M
Unconventional myosins and the regulation of gut barrier integrity and restitution during inflammationR01DK126702 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI IVANOV, ANDREI IVANOVICH · 2020 to 2022
$1.4M
Antiviral role of Condensin IIR21AI153780 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI LONGWORTH, MICHELLE S, O'CONNOR, CHRISTINE M · 2021 to 2022
$443k
Intramural NIH HHS ZIA EB000094NIAID NIH HHS R21 AI153780NIDDK NIH HHS R01 DK108278NIDDK NIH HHS R01 DK123233NIDDK NIH HHS R01 DK126702NIGMS NIH HHS R35 GM119617
6 · The paper itself

Abstract

The actomyosin cytoskeleton serves as a key regulator of the integrity and remodeling of epithelial barriers by controlling assembly and functions of intercellular junctions and cell-matrix adhesions. Although biochemical mechanisms that regulate the activity of non-muscle myosin II (NM-II) in epithelial cells have been extensively investigated, little is known about assembly of the contractile myosin structures at the epithelial adhesion sites. UNC-45A is a cytoskeletal chaperone that is essential for proper folding of NM-II heavy chains and myofilament assembly. We found abundant expression of UNC-45A in human intestinal epithelial cell (IEC) lines and in the epithelial layer of the normal human colon. Interestingly, protein level of UNC-45A was decreased in colonic epithelium of patients with ulcerative colitis. CRISPR/Cas9-mediated knock-out of UNC-45A in HT-29cf8 and SK-CO15 IEC disrupted epithelial barrier integrity, impaired assembly of epithelial adherence and tight junctions and attenuated cell migration. Consistently, decreased UNC-45 expression increased permeability of the Drosophila gut in vivo. The mechanisms underlying barrier disruptive and anti-migratory effects of UNC-45A depletion involved disorganization of the actomyosin bundles at epithelial junctions and the migrating cell edge. Loss of UNC-45A also decreased contractile forces at apical junctions and matrix adhesions. Expression of deletion mutants revealed roles for the myosin binding domain of UNC-45A in controlling IEC junctions and motility. Our findings uncover a novel mechanism that regulates integrity and restitution of the intestinal epithelial barrier, which may be impaired during mucosal inflammation.

Indexed as

ActomyosinMyosinsEpithelial CellsHumansIntercellular JunctionsIntestinal MucosaMolecular ChaperonesTight JunctionsActomyosinMolecular ChaperonesMyosinsadherens junctionscell migrationepithelial barriersmyosinstight junctions

Identifiers

PMID35344227
PMCPMC9044500
OpenAlexW4225311944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.